03.05.2021 - By ReachMD
Host: John Buse, MD, PhD
Guest: Antonios Douros, MD
Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.